Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,749 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,749 | N/A | N/A | N/A | N/A |
| Operating Expenses | 7,880 | 5,640 | 4,538 | 4,938 | 6,508 |
| Operating Income | -6,131 | 34,210 | -4,538 | -4,938 | -6,508 |
| Interest Expense | 0 | 0 | 0 | 4 | 5 |
| Other Income | 340 | 46 | 7 | 15 | -82 |
| Pre-tax Income | -5,791 | 34,256 | -4,531 | -4,927 | -6,595 |
| Net Income Continuous | -5,791 | 33,941 | -4,531 | -4,927 | -6,595 |
| Net Income | $-5,791 | $33,941 | $-4,531 | $-4,927 | $-6,595 |
| EPS Basic Total Ops | -0.28 | 1.72 | -0.22 | -0.25 | -0.35 |
| EPS Basic Continuous Ops | -0.28 | 1.72 | -0.22 | -0.25 | -0.35 |
| EPS Diluted Total Ops | -0.28 | 1.69 | -0.22 | -0.25 | -0.35 |
| EPS Diluted Continuous Ops | -0.28 | 1.69 | -0.22 | -0.25 | -0.35 |
| EBITDA(a) | $-6,130 | $-5,639 | $-4,537 | $-4,937 | $-6,507 |